239 related articles for article (PubMed ID: 29391808)
1. The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway.
Jia L; Tian Y; Chen Y; Zhang G
Onco Targets Ther; 2018; 11():313-321. PubMed ID: 29391808
[TBL] [Abstract][Full Text] [Related]
2. H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-κB signaling.
Duan S; Li M; Wang Z; Wang L; Liu Y
Onco Targets Ther; 2018; 11():6395-6404. PubMed ID: 30323617
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy.
Jiang P; Wang P; Sun X; Yuan Z; Zhan R; Ma X; Li W
Onco Targets Ther; 2016; 9():3501-9. PubMed ID: 27366087
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
Tomar VS; Patil V; Somasundaram K
Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
[TBL] [Abstract][Full Text] [Related]
5. Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition.
Wang J; Zhou F; Li Y; Li Q; Wu Z; Yu L; Yuan F; Liu J; Tian Y; Cao Y; Zhao Y; Zheng Y
Cell Cycle; 2017; 16(24):2355-2365. PubMed ID: 29108461
[TBL] [Abstract][Full Text] [Related]
6. The Silencing of LncRNA-H19 Decreases Chemoresistance of Human Glioma Cells to Temozolomide by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway [Retraction].
Onco Targets Ther; 2022; 15():329-330. PubMed ID: 35418757
[TBL] [Abstract][Full Text] [Related]
7. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
[TBL] [Abstract][Full Text] [Related]
8. Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy.
Lv QL; Wang LC; Li DC; Lin QX; Shen XL; Liu HY; Li M; Ji YL; Qin CZ; Chen SH
Front Pharmacol; 2020; 11():560543. PubMed ID: 33362537
[TBL] [Abstract][Full Text] [Related]
9. H19/miR-152-3p/TCF4 axis increases chemosensitivity of gastric cancer cells through suppression of epithelial-mesenchymal transition.
Jiang X; Ding W; Shen W; Jin J
Transl Cancer Res; 2020 Jun; 9(6):3915-3925. PubMed ID: 35117758
[TBL] [Abstract][Full Text] [Related]
10. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
11. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
Chen Z; Wei X; Shen L; Zhu H; Zheng X
Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-XIST interacts with
Du P; Zhao H; Peng R; Liu Q; Yuan J; Peng G; Liao Y
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28831025
[TBL] [Abstract][Full Text] [Related]
14. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
[TBL] [Abstract][Full Text] [Related]
16. Silencing of Long Non-Coding RNA HOTAIR Alleviates Epithelial-Mesenchymal Transition in Pancreatic Cancer via the Wnt/β-Catenin Signaling Pathway.
Tang Y; Song G; Liu H; Yang S; Yu X; Shi L
Cancer Manag Res; 2021; 13():3247-3257. PubMed ID: 33883938
[TBL] [Abstract][Full Text] [Related]
17. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
[TBL] [Abstract][Full Text] [Related]
18. Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties.
Bhuvanalakshmi G; Arfuso F; Millward M; Dharmarajan A; Warrier S
PLoS One; 2015; 10(6):e0127517. PubMed ID: 26030909
[TBL] [Abstract][Full Text] [Related]
19. A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma.
Song Y; Hu Z; Long H; Peng Y; Zhang X; Que T; Zheng S; Li Z; Wang G; Yi L; Liu Z; Fang W; Qi S
J Neurooncol; 2014 Sep; 119(2):285-95. PubMed ID: 24986090
[TBL] [Abstract][Full Text] [Related]
20. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma.
Ni H; Ji D; Li J; Zhao Z; Zuo J
Int J Biol Macromol; 2021 Apr; 176():145-156. PubMed ID: 33571591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
